Nine patients with high-grade glioma (1 case of HLA-A*0201, 8 of A*2402) were enrolled into a phase I study and given HLA-A2 or A24-peptide cocktail-pulsed mature DCs, which produced a large amount of IL-12. This evidence concerns the gene HLA-A and central nervous system cancer.